tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2017-1-30-36tumors-324Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL REPORTSРеконструкция молочной железы и лучевая терапияBreast reconstruction and radiotherapyЗЕРНОВК. Ю.ZERNOVK. Y.

к. м.н., научный сотрудник отделения опухолей молочной железы

MD, PhD, researcher of breast cancer department

konstantin_zernov@hotmail.comДАШЯНГ. А.DASHYANG. A.

д. м.н., ведущий научный сотрудник отделения опухолей молочной железы

MD, PhD, DSc, leading researcher of breast cancer department

dgarik@mail.ruКРИВОРОТЬКОП. В.KRIVOROTKOP. V.

д. м.н., зав. отделением опухолей молочной железы

MD, PhD, DSc, head of breast cancer department

dr.krivorotko@mail.ruНОВИКОВС. Н.NOVIKOVS. N.

д. м.н., заведующий отделением лучевой терапии

MD, PhD, DSc, head of radiotherapy department

krokon@mail.ruПАЛТУЕВР. М.PALTUEVR. M.

к. м.н., научный сотрудник отделения опухолей молочной железы

MD, PhD, researcher of breast cancer department

paltuev@mail.ruТАБАГУАТ. Т.TABAGUAT. T.

к. м.н., научный сотрудник отделения опухолей молочной железы

MD, PhD, researcher of breast cancer department,

tedo8308@mail.ruЖИЛЬЦОВАЕ. К.ZHILTSOVAE. K.

к. м.н., врач отделения опухолей молочной железы

MD, Ph, researcher of breast cancer department

ziltsova@yandex.ruОПЕРМАНАСЮ. А.OPERMANASY. A.

клинический ординатор кафедры онкологии

resident

opjurij@gmail.comЕМЕЛЬЯНОВА. С.EMELIANOVA. S.

клинический ординатор

resident

ae28111992@yandex.ruЕРЕЩЕНКОС. С.ERESHENKOS. S.

клинический ординатор

resident

seriy_1111@mail.ruПЕТРОВАА. П.PETROVAA. P.

клинический ординатор

resident

avpetrova91@mail.ruКАНАЕВС. В.KANAEVS. V.СЕМИГЛАЗОВВ. Ф.SEMIGLAZOVV. F.

член-корр. РАН, профессор, заведующий отдела опухолей репродуктивной системы и научным отделением опухолей молочной железы

MD, PhD, DSc, professor head of reproductive cancer department

ssemiglazov@mail.ruФГБУ «НИИ онкологии им. Н. Н. Петрова»РоссияFederal State Budget Institution «Research Oncology Institute named after N. N. Petrov» Ministry of HealthRussian FederationГБОУ ВПО ПСПбГМУ им. акад. И. П. Павлова Минздрава РоссииРоссияFederal State Budget Institution «Pavlov First Saint Petersburg State Medical University» Ministry of HealthRussian Federation201704072017013036Copyright © ЗЕРНОВ К.Ю., ДАШЯН Г.А., КРИВОРОТЬКО П.В., НОВИКОВ С.Н., ПАЛТУЕВ Р.М., ТАБАГУА Т.Т., ЖИЛЬЦОВА Е.К., ОПЕРМАНАС Ю.А., ЕМЕЛЬЯНОВ А.С., ЕРЕЩЕНКО С.С., ПЕТРОВА А.П., КАНАЕВ С.В., СЕМИГЛАЗОВ В.Ф., 20172017ЗЕРНОВ К.Ю., ДАШЯН Г.А., КРИВОРОТЬКО П.В., НОВИКОВ С.Н., ПАЛТУЕВ Р.М., ТАБАГУА Т.Т., ЖИЛЬЦОВА Е.К., ОПЕРМАНАС Ю.А., ЕМЕЛЬЯНОВ А.С., ЕРЕЩЕНКО С.С., ПЕТРОВА А.П., КАНАЕВ С.В., СЕМИГЛАЗОВ В.Ф.ZERNOV K.Y., DASHYAN G.A., KRIVOROTKO P.V., NOVIKOV S.N., PALTUEV R.M., TABAGUA T.T., ZHILTSOVA E.K., OPERMANAS Y.A., EMELIANOV A.S., ERESHENKO S.S., PETROVA A.P., KANAEV S.V., SEMIGLAZOV V.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/324

В последние годы отмечаются значительные продвижения в области ауто- и гетерологических реконструкций молочных желез. Реконструкция с помощью имплантатов при мастэктомии используется все чаще. Недавнее исследование, проведенное Albronoz с соавторами, на основе данных Nationwide Inpatient Sample с 1998 по 2008 год, выявило увеличение частоты одномоментных реконструкций имплантатами в среднем на 11% в год, по сравнению с аутологичными методами реконструкции [Barreau-Pouhaer L., 1992]. Возможной причиной для этого увеличения является растущее число молодых, нуждающихся в мастэктомии и не располагающих достаточной жировой клетчаткой для аутологичной реконструкции. Цель реконструкции – достичь долгосрочного, безопасного с онкологических позиций и эстетически удовлетворительного результата с рациональными затратами на операцию. Лучевая терапия после мастэктомии, как часть комплексного лечения, требуется все большему числу больных при раке молочной железы. Она, хотя и  является важнейшим  компонентом в лечении рака молочной железы, связана с высокой частотой возникновения осложнений. Следует надлежащим образом консультировать пациентово возможности этих потенциальных осложнений, с тем, чтобы они могли принимать обоснованные решения.

In recent years there were significant advances in auto- and heterological breast reconstruction. Reconstruction with implants after mastectomy is being used more of ten. A recent study conducted by Albronoz et al, based on Nationwide Inpatient Sample data, found an increasing rate of immediate breast reconstruction with implants af ter mastectomy up to 11%, compared to autological methods of reconstruction [Barreau-Pouhaer L., 1992]. A possible reason for this increase is the growing number of young patients who need a mastectomy, but have not enough fat tissue for autological reconstruction. The purpose of reconstruction is to reach a long-term, oncologically safe and aesthetically pleasing result with reasonable operation expenses. Radiation therapy after mastectomy, as part of a complex treatment, is needed for an increasing amount of patients with breast cancer. Radiation therapy is a vital par t of cancer treatment, but often causes complications. Patients should be informed and consulted about potential complications so they can make reasonable decisions about their treatment.

рак молочной железыреконструкциялучевая терапияосложненияbreast cancerreconstructionradiotherapycomplicationsReferencesASPS (American Society of Plastic Surgeons): Evidencebased clinicalpractice guideline: Breast reconstruction with expanders and implants. www.plasticsurgery.org/ reconstructive-procedures/ breast-reconstruction.html; 2013 (last accessed on 1 July 2015).ASPS (American Society of Plastic Surgeons): Evidencebased clinicalpractice guideline: Breast reconstruction with expanders and implants. www.plasticsurgery.org/ reconstructive-procedures/ breast-reconstruction.html; 2013 (last accessed on 1 July 2015).Albornoz C.R., Bach P.B., Mehrara B.J. et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013; 131:15–23. [PubMed: 23271515].Albornoz C.R., Bach P.B., Mehrara B.J. et al. A paradigm shift in U.S. breast reconstruction: increasing implant rates. Plast Reconstr Surg. 2013; 131:15–23. [PubMed: 23271515].Albornoz C.R., Bach P.B., Mehrara B.J. et al.: A paradigm shift in U. S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg 2013; 131: 15–23.Albornoz C.R., Bach P.B., Mehrara B.J. et al.: A paradigm shift in U. S. Breast reconstruction: increasing implant rates. Plast Reconstr Surg 2013; 131: 15–23.American Society of Plastic Surgeons. 2011 Reconstructive Breast Procedures. Available at: http:// www.plasticsurgery. org/Documents/news-resources/statistics/2011statistics/20011_Stats_Full_Reportpdf.American Society of Plastic Surgeons. 2011 Reconstructive Breast Procedures. Available at: http:// www.plasticsurgery. org/Documents/news-resources/statistics/2011statistics/20011_Stats_Full_Reportpdf.Anderson P.R., Hanlon A.L., Fowble B.L., McNeeley S.W., Freedman G.M. Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy. Int J Radiat Oncol Biol Phys. 2004; 59(4):1080–1087 [PubMed: 15234042].Anderson P.R., Hanlon A.L., Fowble B.L., McNeeley S.W., Freedman G.M. Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapy. Int J Radiat Oncol Biol Phys. 2004; 59(4):1080–1087 [PubMed: 15234042].Berbers J., van Baardwijk A., Houben R. et al.: Reconstruction: before or after postmastectomy radiotherapy?’ A systematic review of the literature. Eur J Cancer 2014; 50: 2752–62.Berbers J., van Baardwijk A., Houben R. et al.: Reconstruction: before or after postmastectomy radiotherapy?’ A systematic review of the literature. Eur J Cancer 2014; 50: 2752–62.Cemal Y., Albornoz C.R., Disa J.J. et al.: A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 2013; 131: 320e‑6e.Cemal Y., Albornoz C.R., Disa J.J. et al.: A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 2013; 131: 320e‑6e.Chang E.I., Chang E.I., Soto-Miranda M.A. et al.: Comprehensive e valuation of risk factors and management of impending flap loss in 2138 breast free flaps. Ann Plast Surg 2014; Epub ahead of print.Chang E.I., Chang E.I., Soto-Miranda M.A. et al.: Comprehensive e valuation of risk factors and management of impending flap loss in 2138 breast free flaps. Ann Plast Surg 2014; Epub ahead of print.Colwell A.S., Damjanovic B., Zahedi B., Medford- Davis L., Hertl C., Austen W.G., Jr.: Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 2011; 128: 1170–8.Colwell A.S., Damjanovic B., Zahedi B., Medford- Davis L., Hertl C., Austen W.G., Jr.: Retrospective review of 331 consecutive immediate single-stage implant reconstructions with acellular dermal matrix: indications, complications, trends, and costs. Plast Reconstr Surg 2011; 128: 1170–8.Contant C.M., van Geel A.N., van der Holt B., Griep C., Tjong Joe Wai R., Wiggers T. Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol. 2000; 26(4):344–350 [PubMed: 10873353].Contant C.M., van Geel A.N., van der Holt B., Griep C., Tjong Joe Wai R., Wiggers T. Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol. 2000; 26(4):344–350 [PubMed: 10873353].Cordeiro P.G., McCarthy C.M. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006; 118(4):832–839 [PubMed: 16980843].Cordeiro P.G., McCarthy C.M. A single surgeon’s 12-year experience with tissue expander/implant breast reconstruction: part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg. 2006; 118(4):832–839 [PubMed: 16980843].Covelli A.M., Baxter N.N., Fitch M.I., Wright F.C.: Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: a comparative analysis between Canada and the United States. Ann Surg Oncol 2014; 21: 3173–84.Covelli A.M., Baxter N.N., Fitch M.I., Wright F.C.: Increasing mastectomy rates-the effect of environmental factors on the choice for mastectomy: a comparative analysis between Canada and the United States. Ann Surg Oncol 2014; 21: 3173–84.Drucker-Zertuche M., Bargallo-Rocha E., Zamora-Del R.R.: Radiotherapy and immediate expander/implant breast reconstruction: should reconstruction be delayed? Breast J. 2011; 17: 365–70.Drucker-Zertuche M., Bargallo-Rocha E., Zamora-Del R.R.: Radiotherapy and immediate expander/implant breast reconstruction: should reconstruction be delayed? Breast J. 2011; 17: 365–70.D’Souza N., Darmanin G., and Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane. Database. Syst. Rev. 7: 2011.CD008674.D’Souza N., Darmanin G., and Fedorowicz Z. Immediate versus delayed reconstruction following surgery for breast cancer. Cochrane. Database. Syst. Rev. 7: 2011.CD008674.Eriksson M., Anveden L., Celebioglu F. et al.: Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort. Breast Cancer Res Treat 2013; 142: 591–601.Eriksson M., Anveden L., Celebioglu F. et al.: Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort. Breast Cancer Res Treat 2013; 142: 591–601.Francis S.H., Ruberg R.L., Stevenson K.B. et al.: Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124: 1790–6.Francis S.H., Ruberg R.L., Stevenson K.B. et al.: Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg 2009; 124: 1790–6.Gurunluoglu R., Gurunluoglu A., Williams S.A., Tebockhorst S.: Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg 2013; 70: 103–10.Gurunluoglu R., Gurunluoglu A., Williams S.A., Tebockhorst S.: Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010. Ann Plast Surg 2013; 70: 103–10.Habermann E.B., Thomsen K.M., Hieken T.J., Boughey J.C.: Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Ann Surg Oncol 2014; 21: 3290–6.Habermann E.B., Thomsen K.M., Hieken T.J., Boughey J.C.: Impact of availability of immediate breast reconstruction on bilateral mastectomy rates for breast cancer across the United States: data from the nationwide inpatient sample. Ann Surg Oncol 2014; 21: 3290–6.Hershman D.L., Richards C.A., Kalinsky K. et al.: Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Res Treat 2012; 136: 535–45.Hershman D.L., Richards C.A., Kalinsky K. et al.: Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Res Treat 2012; 136: 535–45.Hirsch E.M., Seth A.K., Dumanian G.A. et al. Outcomes of tissue expander/implant breast reconstruction in the setting of prereconstruction radiation. Plast Reconstr Surg. 2012; 129:354–361 [PubMed: 22286418].Hirsch E.M., Seth A.K., Dumanian G.A. et al. Outcomes of tissue expander/implant breast reconstruction in the setting of prereconstruction radiation. Plast Reconstr Surg. 2012; 129:354–361 [PubMed: 22286418].Ho A.L., Klassen A.F., Cano S., Scott A.M., Pusic A.L.: Optimizing patient-centered care in breast reconstruction: the importance of preoperative information and patient-physician communication. Plast Reconstr Surg 2013; 132: 212e‑20e.Ho A.L., Klassen A.F., Cano S., Scott A.M., Pusic A.L.: Optimizing patient-centered care in breast reconstruction: the importance of preoperative information and patient-physician communication. Plast Reconstr Surg 2013; 132: 212e‑20e.J agsi R., Jiang J., Momoh A.O. et al.: Complications after mastectomy and immediate breast reconstruction for breast cancer: A claims-based analysis. Ann Surg 2015 (Epub ahead of print).J agsi R., Jiang J., Momoh A.O. et al.: Complications after mastectomy and immediate breast reconstruction for breast cancer: A claims-based analysis. Ann Surg 2015 (Epub ahead of print).Jhaveri J.D,. Rush S.C., Kostroff K. et al. Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int J Radiat Oncol Biol Phys. 2008; 72:859–865 [PubMed: 18472362].Jhaveri J.D,. Rush S.C., Kostroff K. et al. Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int J Radiat Oncol Biol Phys. 2008; 72:859–865 [PubMed: 18472362].McCarthy C.M., Mehrara B.J., Riedel E. et al. Predicting complications following expander/implant breast reconstruction: An outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008; 121:1886–1892 [PubMed: 18520873].McCarthy C.M., Mehrara B.J., Riedel E. et al. Predicting complications following expander/implant breast reconstruction: An outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg. 2008; 121:1886–1892 [PubMed: 18520873].Momoh A.O., Colakoglu S., de Blacam C., Gautam S., Tobias A.M., Lee B.T.: Delayed autologous breast reconstruction after postmastectomy radiation therapy: is there an optimal time? Ann Plast Surg 2012; 69: 14–8.Momoh A.O., Colakoglu S., de Blacam C., Gautam S., Tobias A.M., Lee B.T.: Delayed autologous breast reconstruction after postmastectomy radiation therapy: is there an optimal time? Ann Plast Surg 2012; 69: 14–8.Neuburger J., Macneill F., Jeevan R., van der Meulen J.H., Cromwell D.A.: Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ open 2013; 3.Neuburger J., Macneill F., Jeevan R., van der Meulen J.H., Cromwell D.A.: Trends in the use of bilateral mastectomy in England from 2002 to 2011: retrospective analysis of hospital episode statistics. BMJ open 2013; 3.Pusic A.L., Klassen A.F., Scott A.M., Klok J.A., Cordeiro P.G., Cano S.J.: Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg 2009; 124: 345–53.Pusic A.L., Klassen A.F., Scott A.M., Klok J.A., Cordeiro P.G., Cano S.J.: Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg 2009; 124: 345–53.Spear S.L., Baker J.L. Jr. Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg. 1995; 96:1119–1123. discussion 1124 [PubMed: 7568488].Spear S.L., Baker J.L. Jr. Classification of capsular contracture after prosthetic breast reconstruction. Plast Reconstr Surg. 1995; 96:1119–1123. discussion 1124 [PubMed: 7568488].Spear S.L., Boehmler J.H., Bogue D.P. et al. Options in reconstructing the irradiated breast. Plast Reconstr Surg. 2008; 122:379–388 [PubMed: 18626353].Spear S.L., Boehmler J.H., Bogue D.P. et al. Options in reconstructing the irradiated breast. Plast Reconstr Surg. 2008; 122:379–388 [PubMed: 18626353].Spear S.L., Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg. 2000; 105(3):930–942 [PubMed: 10724252].Spear S.L., Onyewu C. Staged breast reconstruction with saline-filled implants in the irradiated breast: recent trends and therapeutic implications. Plast Reconstr Surg. 2000; 105(3):930–942 [PubMed: 10724252].Spear S.L., Seruya M., Rao S.S. et al. Two-Stage Prosthetic Breast Reconstruction Using AlloDerm Including Outcomes of Different Timings of Radiotherapy. Plast Reconstr Surg. 2012; 130:1–9 [PubMed: 22743866].Spear S.L., Seruya M., Rao S.S. et al. Two-Stage Prosthetic Breast Reconstruction Using AlloDerm Including Outcomes of Different Timings of Radiotherapy. Plast Reconstr Surg. 2012; 130:1–9 [PubMed: 22743866].Yueh J.H., Slavin S.A., Adesiyun T. et al.: Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg 2010; 125: 1585–95.Yueh J.H., Slavin S.A., Adesiyun T. et al.: Patient satisfaction in postmastectomy breast reconstruction: a comparative evaluation of DIEP, TRAM, latissimus flap, and implant techniques. Plast Reconstr Surg 2010; 125: 1585–95.

The authors declare that there are no conflicts of interest present.